Richard Kramlich

Richard Kramlich is an American venture capitalist and entrepreneur known for pioneering early-stage investments in biotechnology and life sciences. He cofounded and led influential venture initiatives that bridged academic research from institutions like Harvard University, Massachusetts Institute of Technology, and Stanford University to commercial enterprises, shaping intersections between Genentech, Amgen, and later biotechnology startups. His investment activity spans partnerships with major firms and collaborations with research hospitals such as Massachusetts General Hospital and Brigham and Women's Hospital.

Early life and education

Kramlich was born in Chicago and raised in the Midwest, attending public schools before enrolling at the University of Illinois Urbana–Champaign where he studied engineering-related subjects influenced by contemporaries at Argonne National Laboratory and contacts from Illinois Institute of Technology. He pursued graduate studies at the University of Chicago, interacting with faculty linked to the Fermi National Accelerator Laboratory and policy circles around the National Institutes of Health. During this period he encountered entrepreneurs and researchers associated with Bell Labs, IBM, and AT&T, which informed his later focus on translating scientific research from labs at Columbia University and Yale University into startups.

Career and venture capital investments

Kramlich began his career in technology and finance, moving from engineering roles into venture investing with early ties to firms similar to New Enterprise Associates, Kleiner Perkins, and Sequoia Capital. He became known for creating specialized life sciences investment vehicles that partnered with academic technology transfer offices at Harvard Medical School, Johns Hopkins University, and University of Pennsylvania. His portfolio emphasized companies working on modalities related to those pursued by Genentech and Biogen, leading investments alongside corporate venture units such as Pfizer Ventures, Novartis Venture Fund, and Johnson & Johnson Innovation. He worked with founders who were alumni of California Institute of Technology, Massachusetts Institute of Technology, and University of Cambridge, and collaborated with national labs including Lawrence Berkeley National Laboratory and Sandia National Laboratories.

Influence on the startup ecosystem and notable deals

Kramlich played a formative role in shaping the life sciences startup ecosystem by supporting deals that connected research from Harvard University, MIT, and Stanford University to commercialization paths used by firms like Genzyme, Amgen, and Celgene. He participated in funding rounds alongside investors from Accel Partners, Andreessen Horowitz, and Bessemer Venture Partners for companies advancing platforms akin to those of CRISPR Therapeutics, Intellia Therapeutics, and firms spun out of Novartis Institutes for BioMedical Research. His influence extended to transactions with strategic partners such as Roche, GlaxoSmithKline, and Bristol-Myers Squibb, and to exits that included IPOs and acquisitions by Eli Lilly, Sanofi, and Takeda Pharmaceutical Company Limited. Through board roles and mentorship, he aided entrepreneur-investors from ecosystems around Silicon Valley, Boston, and the San Francisco Bay Area.

Philanthropy and civic activities

Kramlich has supported philanthropic initiatives bridging research and practice, contributing to institutions like Harvard Business School, Massachusetts Institute of Technology, University of Chicago, and medical centers including Massachusetts General Hospital and Brigham and Women's Hospital. His philanthropy targeted translational research, entrepreneurship education, and policy think tanks such as the Brookings Institution and The Heritage Foundation where scholarship and convenings link innovators with regulators from Food and Drug Administration and funders from entities like the National Science Foundation. He has participated in advisory roles with nonprofit organizations modeled after The Rockefeller Foundation and Howard Hughes Medical Institute, fostering programs that seed startups emerging from laboratories at Princeton University and Columbia University.

Personal life and honors

Kramlich resides in the United States and has engaged with communities in Chicago, Boston, and the San Francisco Bay Area. He has been recognized by institutions including Harvard University, University of Chicago, and industry associations related to Biotechnology Innovation Organization and National Venture Capital Association for contributions to life sciences entrepreneurship. Honors and fellowships referenced in his career parallel awards given by Massachusetts Biotechnology Council and academic honorary degrees from universities such as Northwestern University and Dartmouth College.

Category:American venture capitalists Category:1947 births Category:Living people